Latest Press Releases

Loading…
See all Press Releases

Financial Calendar

Interim report Q2, 2019
Interim report Q3, 2019
Year-end report 2019

Contact Investor Relations
Martin Åmark, CEO/IR
+46 (0) 763 09 37 77
martin.amark@xbrane.com

Company
Presentation

Financial Hearings
Börsveckan
Stockholm, Sweden
February 19, 2019

Presenter:

Martin Åmark, CEO Xbrane Biopharma